XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
6 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Mar. 31, 2020
Mar. 31, 2019
Cash Flows from Operating Activities        
Net Loss $ (1,764,859) $ (904,927) $ (1,337,347) $ (133,811)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock compensation 89,333 688,000 688,000 51,368
Depreciation and amortization 66,855 10,053 62,739 12,951
Gain on bargain purchase     (52,583) 0
Loss note receivable forgiveness 0 27,000    
Loss on modification of debt 18,281 0 50,756 0
Loss on extinguishment of debt 64,194 50,756 81,887 0
Gain on settlement of debt (10,080) 0    
Grant income (2,000) 0    
Loss on disposition of subsidiary     20,790 0
Amortization of debt discount 103,266 0 51,343 0
Gain on changes in fair value of compound embedded derivative 787,407 0 (119,902) 0
Changes in operating assets & liabilities        
Prepaid expenses and other current assets (2,325) (19,329) 3,140 (5,126)
Inventory 5,811 0 2,744 1,740
Accounts payable and accrued liabilities 42,581 (36,495) (10,983) 9,818
Deferred revenue 26,597 0 (6,430) 0
Deferred compensation     0 1,600
Net cash used in operating activities (574,939) (184,942) (565,845) (61,460)
Cash Flows from Investing Activities        
Business acquisition, net of cash acquired     (42,609) 0
Payments to related parties (470) (174,245) (173,533) (65,416)
Capital expenditures (128,031) (31,985) (84,688) (3,260)
Net cash used in investing activities (128,501) (206,230) (300,830) (68,676)
Cash Flows from Financing Activities        
Proceeds from convertible notes 150,000   725,499 52,450
Proceeds from notes payable 122,766 0    
Repayments related to payable due for business combinations (15,000) 0    
Issuance of common stock 465,000 400,000 400,000 133,832
Repayment on notes payable (4,484) 0 (20,532) (45,035)
Purchase of outstanding common stock     (189,141) 0
Payment of acquisition payable     (30,000) 0
Net cash provided by financing activities 718,282 400,000 885,826 141,247
Increase (decrease) in cash and cash equivalents 14,842 8,828 19,150 11,111
Cash and cash equivalents at beginning of period 46,729 27,579 27,579 16,468
Cash and cash equivalents at end of period 61,571 36,407 46,729 27,579
Supplemental Cash Flow Information        
Cash paid for interest 599 0 0 1,443
Cash paid for income taxes 0 0 0 0
Non-cash investing and financing activities:        
Cancellation of outstanding shares in exchange cancellation of notes receivable - related party     $ 157,773 $ 0
Assets acquired in business combination through the issuance of stock     185,400 0
Acquisition payable from sellers due to acquisitions     $ 45,000 $ 0
Initial recognition of derivative liability as debt discount     178,692 0
Assets acquired on acquisition     428,747 0
Liabilities acquired on acquisition     155,739 0
Conversion of note payable to equity $ 490,457 $ 59,400 $ 0 $ 59,400